Information:
Fel:
ID
22836
Beskrivning
Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00705822
Länk
https://clinicaltrials.gov/show/NCT00705822
Nyckelord
Versioner (1)
- 2017-06-12 2017-06-12 -
Uppladdad den
12 juni 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Prostatic Neoplasms NCT00705822
Eligibility Prostatic Neoplasms NCT00705822
- StudyEvent: Eligibility
Similar models
Eligibility Prostatic Neoplasms NCT00705822
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Adenocarcinoma of prostate
Item
histological or cytological confirmation of prostate adenocarcinoma
boolean
C0007112 (UMLS CUI [1])
Prostate carcinoma Advanced
Item
advanced prostate carcinoma.
boolean
C0600139 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0205179 (UMLS CUI [1,2])
Hormone Therapy
Item
previous treatment with hormones
boolean
C0279025 (UMLS CUI [1])
Testosterone measurement
Item
levels of testosterone < 50 ng/dl
boolean
C0523912 (UMLS CUI [1])
Hematologic function | Liver function | Renal function
Item
good hematological, liver and kidney function
boolean
C0221130 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Operative Surgical Procedures | Therapeutic radiology procedure | Adverse effects Patient recovered
Item
previous treatment with surgery or radiotherapy, at least 4 weeks since end of treatment is allowed (the patient should have been recovered from any side effects.
boolean
C0543467 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0879626 (UMLS CUI [3,1])
C1115804 (UMLS CUI [3,2])
C1522449 (UMLS CUI [2])
C0879626 (UMLS CUI [3,1])
C1115804 (UMLS CUI [3,2])
Chemotherapy | Estramustine
Item
previous chemotherapy (estramustine included).
boolean
C0392920 (UMLS CUI [1])
C0014921 (UMLS CUI [2])
C0014921 (UMLS CUI [2])
Hormone Therapy Second line | Estrogens | Progestins | Ketoconazole
Item
second line hormonotherapy (oestrogens, gestagens, ketoconazole, ...included)
boolean
C0279025 (UMLS CUI [1,1])
C1710038 (UMLS CUI [1,2])
C0014939 (UMLS CUI [2])
C0033306 (UMLS CUI [3])
C0022625 (UMLS CUI [4])
C1710038 (UMLS CUI [1,2])
C0014939 (UMLS CUI [2])
C0033306 (UMLS CUI [3])
C0022625 (UMLS CUI [4])
Therapeutic radiology procedure | Therapeutic radiology procedure Bone Marrow Percentage
Item
previous treatment with radiotherapy (isotopes) or previous radiotherapy over > 25% of the marrow
boolean
C1522449 (UMLS CUI [1])
C1522449 (UMLS CUI [2,1])
C0005953 (UMLS CUI [2,2])
C0439165 (UMLS CUI [2,3])
C1522449 (UMLS CUI [2,1])
C0005953 (UMLS CUI [2,2])
C0439165 (UMLS CUI [2,3])
Malignant Neoplasms | Interval Disease Free of | Skin carcinoma
Item
any malignant process with a free disease interval under 5 years, exception done to non-melanoma skin cancer.
boolean
C0006826 (UMLS CUI [1])
C1272706 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C0332296 (UMLS CUI [2,3])
C0699893 (UMLS CUI [3])
C1272706 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C0332296 (UMLS CUI [2,3])
C0699893 (UMLS CUI [3])
Comorbidity Serious
Item
concomitant serious diseases
boolean
C0009488 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,2])
Antineoplastic Therapy | Luteinizing Hormone-releasing Hormone Agonist | Diphosphonates
Item
concomitant treatment with any other neoplassic therapy (exception done to lhrh agonists and/or biphosphonates).
boolean
C2346834 (UMLS CUI [1])
C1518041 (UMLS CUI [2])
C0012544 (UMLS CUI [3])
C1518041 (UMLS CUI [2])
C0012544 (UMLS CUI [3])
Medical contraindication Estramustine
Item
contraindication for the treatment with estramustine.
boolean
C1301624 (UMLS CUI [1,1])
C0014921 (UMLS CUI [1,2])
C0014921 (UMLS CUI [1,2])
Pulmonary Embolism | Thromboembolism | Anticoagulants | Aspirin | Thrombophlebitis | Thrombophilia
Item
previous history of pulmonary embolism, thromboembolic disease, previous treatment with anticoagulants (except aspirin), active thrombophlebitis or hypercoagulation.
boolean
C0034065 (UMLS CUI [1])
C0040038 (UMLS CUI [2])
C0003280 (UMLS CUI [3])
C0004057 (UMLS CUI [4])
C0040046 (UMLS CUI [5])
C0398623 (UMLS CUI [6])
C0040038 (UMLS CUI [2])
C0003280 (UMLS CUI [3])
C0004057 (UMLS CUI [4])
C0040046 (UMLS CUI [5])
C0398623 (UMLS CUI [6])
Spillage Pulmonary | Ascites Pulmonary
Item
previous history of pulmonary spillage or ascitis.
boolean
C0015376 (UMLS CUI [1,1])
C2709248 (UMLS CUI [1,2])
C0003962 (UMLS CUI [2,1])
C2709248 (UMLS CUI [2,2])
C2709248 (UMLS CUI [1,2])
C0003962 (UMLS CUI [2,1])
C2709248 (UMLS CUI [2,2])
Study Subject Participation Status
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean
C2348568 (UMLS CUI [1])